Incidence of Chlamydia trachomatis infection in women in England: Two methods of estimation

Epidemiology and Infection

Volumn 142, Issue 3, 2014, Pages 562-576

  Price, M J ^a   Ades, A E ^b   De Angelis, D ^c,d   Welton, N J ^b   Macleod, J ^b   Turner, K ^b   Horner, P J ^b,e  

^a UNIVERSITY OF BIRMINGHAM   (United Kingdom)

^b UNIVERSITY OF BRISTOL   (United Kingdom)

^c PUBLIC HEALTH ENGLAND   (United Kingdom)

^d MRC BIOSTATISTICS UNIT   (United Kingdom)

^e UNIVERSITY HOSPITALS BRISTOL NHS FOUNDATION TRUST   (United Kingdom)

Author keywords

Bayesian analysis; Chlamydia; Evidence synthesis; Incidence; Multi parameter evidence synthesis

Indexed keywords

ADOLESCENT; ADULT; AGE DISTRIBUTION; ARTICLE; CHLAMYDIA TRACHOMATIS; CHLAMYDIASIS; CONTROLLED STUDY; DISEASE DURATION; DISEASE TRANSMISSION; FEMALE; HUMAN; INCIDENCE; INFECTION RATE; INFECTION RISK; MAJOR CLINICAL STUDY; NONHUMAN; POPULATION RESEARCH; PREVALENCE; REINFECTION; RISK ASSESSMENT; UNITED KINGDOM; CHLAMYDIA INFECTIONS; ENGLAND; MASS SCREENING; CALCULATION; RISK FACTOR;

ADOLESCENT; ADULT; CHLAMYDIA INFECTIONS; CHLAMYDIA TRACHOMATIS; ENGLAND; FEMALE; HUMANS; MASS SCREENING; PREVALENCE;

EID: 84896451686     PISSN: 09502688     EISSN: 14694409     Source Type: Journal    
DOI: 10.1017/S0950268813001027     Document Type: Article

References (29)

1. Health Protection Agency. STI episodes seen in GUM clinics: annual data tables 2011 (http://www.hpa.org. uk/stiannualtables). Accessed 1 November 2010.
2. Adams EJ, Turner KME, Edmunds WJ. The cost effectiveness of opportunistic chlamydia screening in England. Sexually Transmitted Infections 2007; 83: 354-362.
3. Roberts TE, et al. Cost effectiveness of home based population screening for Chlamydia trachomatis in the UK: economic evaluation of chlamydia screening studies (ClaSS) project. British Medical Journal 2007; 335: 291-294A.
4. Turner KME, et al. Modelling the effectiveness of chlamydia screening in England. Sexually Transmitted Infections 2006; 82: 496-502.
5. LaMontagne DS, et al. Incidence and reinfection rates of genital chlamydial infection among women aged 16-24 years attending general practice, family planning and genitourinary medicine clinics in England: a prospective cohort study by the Chlamydia Recall Study Advisory Group. Sexually Transmitted Infections 2007; 83: 292-303.
6. Adams EJ, et al. Chlamydia trachomatis in the United Kingdom: a systematic review and analysis of prevalence studies. Sexually Transmitted Infections 2004; 80: 354-62.
7. Ades AE, Sutton AJ. Multiparameter evidence synthesis in epidemiology and medical decision making: current appoaches. Journal of the Royal Statistical Society, Series A 2006; 169: 5-35.
8. Goubar A, et al. Estimates of human immunodeficiency virus prevalence and proportion diagnosed based on Bayesian multiparameter synthesis of surveillance data. Journal of the Royal Statistical Society, Series A 2008; 171: 541-580.
9. Eddy DM, Hasselblad V, Shachter R. Meta-analysis by the Confidence Profile Method. London: Academic Press, 1992.
10. Lunn DJ, et al. WinBUGS - a Bayesian modeling framework: concepts, structure, and extensibility. Statistics and Computing 2000; 10: 325-337.
11. Price MJ, et al. Mixture-of-exponentials models to explain heterogeneity in studies of the duration of Chlamydia trachomatis infection. Statistics in Medicine 2013; 32: 1547-1560.
12. Korenromp EL, et al. What proportion of episodes of gonorrhoea and chlamydia becomes symptomatic? International Journal of STD & AIDS 2002; 13: 91- 101.
13. Geisler WM. Duration of untreated, uncomplicated Chlamydia trachomatis genital infection and factors associated with chlamydia resolution: a review of human studies. Journal of Infectious Diseases 2010; 201 (Suppl. 2): S104-S113.
14. Golden MR, et al. Duration of untreated genital infections with Chlamydia trachomatis - a review of the literature. Sexually Transmitted Diseases 2000; 27: 329-337.
15. Molano M, et al. The natural course of Chlamydia trachomatis infection in asymptomatic Colombian women: a 5-year follow-up study. Journal of Infectious Diseases 2005; 191: 907-916.
16. Geisler WM, et al. The natural history of untreated Chlamydia trachomatis infection in the interval between screening and returning for treatment. Sexually Transmitted Diseases 2008; 35: 119-123.
17. Rothman KJ, Greenland S, Lash TL. Modern Epidemiology, 3rd edn. Philadelphia: Lippincott, Williams & Wilkins, 2008.
18. Macleod J, et al. Coverage and uptake of systematic postal screening for genital Chlamydia trachomatis and prevalence of infection in the United Kingdom general population: cross sectional study. British Medical Journal 2005; 330: 940-942.
19. Oakeshott P et al. Randomised controlled trial of screening for Chlamydia trachomatis to prevent pelvic inflammatory disease: the POPI (prevention of pelvic infection) trial. British Medical Journal 2010; 340: C1642.
20. Brooks SP, Gelman A. Alternative methods for monitoring convergence of iterative simulations. Journal of Computational and Graphical Statistics 1998; 7: 434-455.
21. Dempster AP. The direct use of likelihood for significance testing. Statistics and Computing 1997; 7: 247-252.
22. Spiegelhalter DJ, et al. Bayesian measures of model complexity and fit. Journal of the Royal Statistical Society Series B: Statistical Methodology 2002; 64: 583-616.
23. Fenton KA, et al. Sexual behaviour in Britain: reported sexually transmitted infections and prevalent genital Chlamydia trachomatis infection. Lancet 2001; 358: 1851-1854.
24. McCadden A, et al. Chlamydia trachomatis testing in the second British national survey of sexual attitudes and lifestyles: respondent uptake and treatment outcomes. Sexually Transmitted Diseases 2005; 32: 387-394.
25. Althaus CL, et al. Transmission dynamics of Chlamydia trachomatis affect the impact of screening programes. Epidemics 2010; 2: 123-131.
26. Office for National Statistics. Census 2001, National Statistics: results on population of England and Wales [CD version], 2003. United Kingdom.
27. Presanis AM, et al. Bayesian evidence synthesis for a transmission dynamic model for HIV among men who have sex with men. Biostatistics 2011; 12: 666-681.
28. Grimmett GDR, Stirzaker DR. Probability and Random Processes, 2nd edn. Oxford: Oxford University Press, 1992.
29. Welton NJ, Ades AE. Estimation of Markov Chain transition probabilities and rates from fully and partially observed data: uncertainty propagation, evidence synthesis and model calibration. Medical Decision Making 2005; 25: 633-645.